Works matching IS 01145916 AND DT 2023 AND VI 46 AND IP 12

Results: 10

Long-Term Real-World Post-approval Safety Data of Multiple Biosimilars from One Marketing-Authorization Holder After More than 18 Years Since Their First Biosimilar Launch.

Published in:

Drug Safety, 2023, v. 46, n. 12, p. 1391, doi. 10.1007/s40264-023-01371-8

By:

Sagi, Sreedhar;
Anjaneya, Pradeep;
Kalsekar, Sameer;
Kottke, Andrea;
Cohen, Hillel P.

Publication type:

Article

Acknowledgement to Referees.

Published in:: Drug Safety, 2023, v. 46, n. 12, p. 1297, doi. 10.1007/s40264-023-01369-2
Publication type:: Article

The Role of ISoP in the Advancement of Pharmacovigilance in Low-and Middle-Income Countries (LMICs).

Published in:

Drug Safety, 2023, v. 46, n. 12, p. 1307, doi. 10.1007/s40264-023-01363-8

By:

Elhawary, Mohamed A.;
Ogar, Comfort K.;
Tarapués, Mónica;
Caro, Angela;
Ndagije, Helen Byomire;
Benabdallah, Ghita;
Sefiani, Houda;
Rostom, Hadir

Publication type:

Article

Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France.

Published in:

Drug Safety, 2023, v. 46, n. 12, p. 1381, doi. 10.1007/s40264-023-01359-4

By:

de Germay, Sibylle;
Singier, Allison;
Salvo, Francesco;
Pariente, Antoine

Publication type:

Article

Sodium-Glucose Cotransporter 2 Inhibitor-Associated "Ketoacidosis" Versus "Diabetic Ketoacidosis": The Importance of Accurate Terminology.

Published in:

Drug Safety, 2023, v. 46, n. 12, p. 1303, doi. 10.1007/s40264-023-01358-5

By:

Milder, Tamara Y.;
Milder, David A.;
Greenfield, Jerry R.;
Day, Richard O.

Publication type:

Article

Pulmonary Toxicity Associated with Immune Checkpoint Inhibitors-Based Therapy: Current Perspectives and Future Directions.

Published in:

Drug Safety, 2023, v. 46, n. 12, p. 1313, doi. 10.1007/s40264-023-01357-6

By:

Hong, Baohui;
Zheng, Jiabing;
Chen, Rong;
Zheng, Caiyun;
Du, Bin;
Ni, Ruping;
Yang, Jing

Publication type:

Article

The Effect of Sex on the Incidence, Latency, Duration and Perceived Burden of Adverse Events Following Seasonal Influenza Vaccination in the Netherlands.

Published in:

Drug Safety, 2023, v. 46, n. 12, p. 1323, doi. 10.1007/s40264-023-01356-7

By:

Slingerland, P.;
van Hunsel, Florence P. A. M.;
Lieber, T.;
van Balveren, L.;
Duijster, J. W.

Publication type:

Article

Comparative Analysis of Information Provided in German Adverse Drug Reaction Reports Sent by Physicians, Pharmacists and Consumers.

Published in:

Drug Safety, 2023, v. 46, n. 12, p. 1363, doi. 10.1007/s40264-023-01355-8

By:

Christ, Patrick;
Dubrall, Diana;
Schmid, Matthias;
Sachs, Bernhardt

Publication type:

Article

Drug Utilisation Patterns of Alternatives to Ranitidine-Containing Medicines in Patients Treated with Ranitidine: A Network Analysis of Data from Six European National Databases.

Published in:

Drug Safety, 2023, v. 46, n. 12, p. 1353, doi. 10.1007/s40264-023-01354-9

By:

Arinze, Johnmary T.;
de Ridder, Maria A. J.;
Vojinovic, Dina;
van Ballegooijen, Hanne;
Markov, Emanuil;
Duarte-Salles, Talita;
Rijnbeek, Peter;
Verhamme, Katia M. C.

Publication type:

Article

Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study.

Published in:

Drug Safety, 2023, v. 46, n. 12, p. 1335, doi. 10.1007/s40264-023-01353-w

By:

Gauffin, Oskar;
Brand, Judith S.;
Vidlin, Sara Hedfors;
Sartori, Daniele;
Asikainen, Suvi;
Català, Martí;
Chalabi, Etir;
Dedman, Daniel;
Danilovic, Ana;
Duarte-Salles, Talita;
García Morales, Maria Teresa;
Hiltunen, Saara;
Jödicke, Annika M.;
Lazarevic, Milan;
Mayer, Miguel A.;
Miladinovic, Jelena;
Mitchell, Joseph;
Pistillo, Andrea;
Ramírez-Anguita, Juan Manuel;
Reyes, Carlen

Publication type:

Article